Latest News

Refractory angina: mechanisms and stratified treatment in obstructive and non-obstructive...

Abstract

The diagnosis of refractory angina has conventionally been limited to patients with angina and ischaemia secondary to obstructive atherosclerotic epicardial coronary disease who experience persistent symptoms despite optimal pharmacological and revascularization therapies. It is now well-established that angina may also be caused by ischaemia resulting from coronary microcirculatory disorders, coronary vasospasm, and bridging in the absence of obstructive epicardial coronary disease or after “successful” revascularization. This increasingly prevalent and symptomatic group of patients, with both angina and demonstrable ischaemia, have been excluded from the conventional definition of refractory angina. In patients with obstructive epicardial coronary disease, disturbed microcirculatory and vasomotor function, amongst other ischaemic mechanisms, may account for continuing symptoms despite revascularization. Under-recognition of these mechanisms results in inadequate treatment and symptom persistence. In this review, a redefinition of refractory angina is proposed to include the full spectrum of patients experiencing persistent angina despite current maximal guideline-directed medical and revascularization therapies. Systematic approaches for comprehensive investigation are suggested to identify underlying mechanisms of ischaemia and stratify treatments accordingly. The complex needs of patients with refractory angina are likely best addressed by an inter-disciplinary Angina Heart Team with the aim of improving patient symptoms, quality of life, and clinical outcomes.

Graphical Abstract A contemporary approach to the stratified management of refractory angina resulting from obstructive and non-obstructive coronary artery disease. Guideline recommended stratified anti-ischaemic therapies are shown in bold. CAD, coronary artery disease; CBT, cognitive behavioural therapy; CFVR, coronary flow velocity reserve; CMD, coronary microvascular dysfunction; CMR, cardiac MRI; CSR, coronary sinus reducer; CT, computed tomography; ECSWT, extracorporeal shockwave therapy; EECP, enhanced external counterpulsation; ETT, exercise tolerance test; LIPUS, low-intensity pulsed ultrasound; PET, positron emission tomography; SCS, spinal cord stimulation; SENS, subcutaneous electrical nerve stimulation; SGB, stellate ganglion block; TENS, transcutaneous electrical nerve stimulation; VSA, vasospastic angina

Introduction

Refractory angina is conventionally diagnosed in patients with angina and demonstrable ischaemia secondary to obstructive epicardial coronary artery disease (CAD) that persists despite maximally tolerated guideline-directed pharmacological therapy and achievable revascularization. It is well-established, however, that angina can also result from ischaemia triggered by other mechanisms, including coronary microvascular dysfunction (CMD), epicardial or microvascular vasospasm, and myocardial bridging. These can occur in the presence or absence of obstructive epicardial CAD, and in patients with persistent angina despite successful coronary revascularization. Patients without flow-limiting CAD who have demonstrable ischaemia due to CMD or vasospasm and experience life-limiting angina fall outside the current definition of refractory angina. Furthermore, CMD and vasospasm can additionally occur in patients with obstructive epicardial CAD, but frequently remain under-recognized and under-treated. Focusing exclusively on obstructive CAD may misclassify patients as having refractory angina, as symptoms might improve with appropriate stratified treatment. Thus, in patients deemed to have refractory angina, it is necessary to evaluate comprehensively the potential pathophysiological mechanisms causing myocardial ischaemia.

A re-definition of refractory angina is urgently needed to encompass the diversity of patients with angina encountered in contemporary clinical practice. In this article, approaches for the systematic non-invasive and invasive identification of ischaemic mechanisms arising from all compartments of the coronary circulation are proposed, emphasising the importance of quantitative methods. An approach to using results of these investigations to stratify treatment is suggested, understanding that multiple mechanisms may co-exist in an individual patient. An integrated approach combining established medical therapies for ischaemia, cardiac rehabilitation (CR), psychological therapies, and advanced pain management is proposed. Building on previous work, a more inclusive definition of refractory angina is suggested together with a model of care, delivered by a specialist inter-disciplinary Angina Heart Team, which may best address the complex needs of patients with refractory angina leading to improved symptoms, quality of life, and clinical outcomes.

Keywords

Share this article

Get Informed

Learn all about the symptoms, causes and triggers of these heart conditions.

Educate. Inform. Enlighten.